What can be learned from the history of recurrence in migraine? A comment

Peer Tfelt-Hansen

doi:10.1007/s10194-009-0144-0

What can be learned from the history of recurrence in migraine? A comment

Peer Tfelt-Hansen

Institut for Klinisk Medicin

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

7 Citationer (Scopus)

Abstract

Udgivelsesdato: 2009-Oct

Originalsprog	Engelsk
Tidsskrift	Journal of Headache and Pain
Vol/bind	10
Udgave nummer	5
Sider (fra-til)	311-5
Antal sider	4
ISSN	1129-2369
DOI	https://doi.org/10.1007/s10194-009-0144-0
Status	Udgivet - 2009

Bibliografisk note

Keywords: Clinical Trials as Topic; Humans; Migraine Disorders; Recurrence; Sumatriptan; Vasoconstrictor Agents

Adgang til dokumentet

10.1007/s10194-009-0144-0

Citationsformater

@article{99992980a92511df928f000ea68e967b,

title = "What can be learned from the history of recurrence in migraine? A comment",

abstract = "Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatriptan. The history of recurrence in early sumatriptan randomised clinical trials is described. Recurrence has been ascribed to patient-dependent factors but experience with ergot alkaloids suggested that recurrence can also be treatment-dependent. Possible mechanisms for recurrence are discussed.",

author = "Peer Tfelt-Hansen",

note = "Keywords: Clinical Trials as Topic; Humans; Migraine Disorders; Recurrence; Sumatriptan; Vasoconstrictor Agents",

year = "2009",

doi = "10.1007/s10194-009-0144-0",

language = "English",

volume = "10",

pages = "311--5",

journal = "Journal of Headache and Pain",

issn = "1129-2369",

publisher = "Springer",

number = "5",

}

TY - JOUR

T1 - What can be learned from the history of recurrence in migraine? A comment

AU - Tfelt-Hansen, Peer

N1 - Keywords: Clinical Trials as Topic; Humans; Migraine Disorders; Recurrence; Sumatriptan; Vasoconstrictor Agents

PY - 2009

Y1 - 2009

N2 - Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatriptan. The history of recurrence in early sumatriptan randomised clinical trials is described. Recurrence has been ascribed to patient-dependent factors but experience with ergot alkaloids suggested that recurrence can also be treatment-dependent. Possible mechanisms for recurrence are discussed.

AB - Recurrence was first recognised as a clinical problem in 1989 with the advent of sumatriptan. The history of recurrence in early sumatriptan randomised clinical trials is described. Recurrence has been ascribed to patient-dependent factors but experience with ergot alkaloids suggested that recurrence can also be treatment-dependent. Possible mechanisms for recurrence are discussed.

U2 - 10.1007/s10194-009-0144-0

DO - 10.1007/s10194-009-0144-0

M3 - Journal article

C2 - 19705060

VL - 10

SP - 311

EP - 315

JO - Journal of Headache and Pain

JF - Journal of Headache and Pain

SN - 1129-2369

IS - 5

ER -